• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型无聚合物混合药物洗脱支架的临床前评估

Preclinical Assessment of a Novel Polymer-Free Hybrid Drug Eluting Stent.

作者信息

Wild Léa, Beele Alicia, Seguchi Masaru, Lenz Tobias, Nicol Philipp, Sabic-Halilcevic Emina, Klosterman Grace R, Kastrati Adnan, Joner Michael

机构信息

Department of Cardiovascular Diseases, German Heart Center Munich, Technical University Munich University Hospital, Lazarettstraße 36, 80636, Munich, Germany.

DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Berlin, Germany.

出版信息

J Cardiovasc Transl Res. 2025 Aug 15. doi: 10.1007/s12265-025-10680-5.

DOI:10.1007/s12265-025-10680-5
PMID:40815367
Abstract

We aimed to evaluate a novel polymer-free hybrid drug eluting stent (DES) relative to benchmark devices and specific controls addressing singular components of the test device in a juvenile pig model of coronary stenting. 80 stents were implanted in 28 juvenile pigs and evaluated at 28 and 90 days using quantitative coronary angiography and histopathology (n = 10 per group). Scanning electron microscopy was used at 14 days to assess early re-endothelialization (n = 3 per group). The test device featured a cobalt-chromium (CoCr) backbone with a polymer-free probucol matrix releasing everolimus. The polymer-free test stent showed improved strut coverage at 28 days compared to the polymer-coated control, with significantly lower neointimal growth at 90 days and near complete endothelialization at 14 days. This preclinical study supports the favorable vascular healing profile of a polymer-free hybrid DES, warranting further clinical investigation.

摘要

我们旨在在幼年猪冠状动脉支架置入模型中,评估一种新型无聚合物混合药物洗脱支架(DES)相对于基准器械以及针对测试器械单一组件的特定对照物的性能。将80个支架植入28只幼年猪体内,并在第28天和第90天使用定量冠状动脉造影和组织病理学进行评估(每组n = 10)。在第14天使用扫描电子显微镜评估早期再内皮化情况(每组n = 3)。测试器械的特点是具有钴铬(CoCr)骨架以及释放依维莫司的无聚合物普罗布考基质。与聚合物涂层对照物相比,无聚合物测试支架在第28天显示出更好的支架覆盖,在第90天新生内膜生长显著更低,在第14天接近完全内皮化。这项临床前研究支持了无聚合物混合DES良好的血管愈合情况,值得进一步进行临床研究。

相似文献

1
Preclinical Assessment of a Novel Polymer-Free Hybrid Drug Eluting Stent.新型无聚合物混合药物洗脱支架的临床前评估
J Cardiovasc Transl Res. 2025 Aug 15. doi: 10.1007/s12265-025-10680-5.
2
Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds: Evidence From a Network Meta-Analysis of 147 Trials.药物洗脱支架和生物可吸收支架的支架内血栓形成:来自 147 项试验的网络荟萃分析证据。
JACC Cardiovasc Interv. 2016 Jun 27;9(12):1203-1212. doi: 10.1016/j.jcin.2016.03.038. Epub 2016 Jun 1.
3
Polymer-free sirolimus- and probucol-eluting stents versus durable polymer-based everolimus-eluting stents for percutaneous coronary revascularization: A prospective multicenter randomized clinical trial.无聚合物西罗莫司和普罗布考洗脱支架与耐用聚合物依维莫司洗脱支架用于经皮冠状动脉血运重建:一项前瞻性多中心随机临床试验。
J Cardiol. 2025 Aug;86(2):148-154. doi: 10.1016/j.jjcc.2025.01.018. Epub 2025 Feb 3.
4
Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography (OCT)-The REPAIR Trial.光学相干断层成像术(OCT)在 1、2、3 个月时对生物可降解聚合物药物洗脱支架的冠状动脉愈合情况进行的连续评估-REPAIR 试验。
J Invasive Cardiol. 2023 May;35(5):E225-E233. doi: 10.25270/jic/22.00349. Epub 2023 Mar 13.
5
Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.生物可吸收聚合物与耐用聚合物载药及裸金属支架的临床疗效:来自综合网络荟萃分析的证据。
J Am Coll Cardiol. 2014 Feb 4;63(4):299-307. doi: 10.1016/j.jacc.2013.09.061. Epub 2013 Nov 6.
6
Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis.可生物降解聚合物药物洗脱支架与裸金属支架与耐用聚合物药物洗脱支架的比较:系统评价和贝叶斯方法网络荟萃分析。
Eur Heart J. 2014 May;35(17):1147-58. doi: 10.1093/eurheartj/eht570. Epub 2014 Jan 23.
7
Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.药物洗脱支架和金属裸支架治疗 ST 段抬高型心肌梗死患者的临床结局:来自综合网络荟萃分析的证据。
J Am Coll Cardiol. 2013 Aug 6;62(6):496-504. doi: 10.1016/j.jacc.2013.05.022. Epub 2013 Jun 7.
8
Five-year outcomes of a drug-coated polymer-free biolimus-eluting stent versus an ultrathin-strut biodegradable-polymer sirolimus-eluting stent.无药物涂层聚合物的生物雷帕霉素洗脱支架与超薄支可降解聚合物西罗莫司洗脱支架的五年随访结果
EuroIntervention. 2025 Jun 2;21(11):e617-e628. doi: 10.4244/EIJ-D-24-00586.
9
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.药物洗脱支架和裸金属支架的支架血栓形成:来自综合网络荟萃分析的证据。
Lancet. 2012 Apr 14;379(9824):1393-402. doi: 10.1016/S0140-6736(12)60324-9. Epub 2012 Mar 23.
10
Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial.ST 段抬高型心肌梗死患者中超薄支架可生物降解与薄支架持久聚合物药物洗脱支架的复杂经皮冠状动脉介入治疗:来自 BIOSTEMI 随机试验的亚组分析。
Catheter Cardiovasc Interv. 2023 Mar;101(4):687-700. doi: 10.1002/ccd.30600. Epub 2023 Feb 19.

本文引用的文献

1
Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis.可生物降解聚合物依维莫司洗脱支架与当代药物洗脱支架的比较:系统评价和荟萃分析。
Sci Rep. 2023 Jan 31;13(1):1715. doi: 10.1038/s41598-022-26654-5.
2
Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials.经皮冠状动脉介入治疗患者中生物可降解聚合物西罗莫司洗脱支架与耐久性聚合物依维莫司洗脱支架的比较:来自 5 项随机试验的个体患者数据的荟萃分析。
Am Heart J. 2021 May;235:140-148. doi: 10.1016/j.ahj.2021.02.009. Epub 2021 Feb 17.
3
10-Year Outcomes From a Randomized Trial of Polymer-Free Versus Durable Polymer Drug-Eluting Coronary Stents.
无聚合物药物洗脱冠状动脉支架与耐用聚合物药物洗脱冠状动脉支架随机临床试验的 10 年结果。
J Am Coll Cardiol. 2020 Jul 14;76(2):146-158. doi: 10.1016/j.jacc.2020.05.026.
4
Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment.血管新生动脉硬化:组织病理学发现概述及其对血管内影像学评估的影响。
Eur Heart J. 2015 Aug 21;36(32):2147-59. doi: 10.1093/eurheartj/ehv205. Epub 2015 May 20.
5
Permanent and biodegradable polymer coatings in the absence of antiproliferative drugs in a porcine model of coronary artery stenting.在猪冠状动脉支架置入模型中,不含抗增殖药物的永久性和可生物降解聚合物涂层。
EuroIntervention. 2016 Jan 22;11(9):1020-6. doi: 10.4244/EIJY14M10_08.
6
Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans.第二代依维莫司洗脱支架与第一代西罗莫司和紫杉醇洗脱支架在人体中的病理学比较。
Circulation. 2014 Jan 14;129(2):211-23. doi: 10.1161/CIRCULATIONAHA.113.001790. Epub 2013 Oct 25.
7
Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation.药物洗脱支架中的血管愈合:支架植入前临床模型中雷帕霉素洗脱支架的药物相关反应差异。
EuroIntervention. 2012 Oct;8(6):752-9. doi: 10.4244/EIJV8I6A115.
8
Polymer coatings and delayed arterial healing following drug-eluting stent implantation.药物洗脱支架植入后的聚合物涂层与动脉愈合延迟
Minerva Cardioangiol. 2009 Oct;57(5):567-84.
9
Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment.经皮冠状动脉介入治疗中的药物洗脱支架:效益-风险评估
Drug Saf. 2009;32(9):749-70. doi: 10.2165/11316500-000000000-00000.
10
Endothelial cell recovery between comparator polymer-based drug-eluting stents.对比聚合物基药物洗脱支架之间的内皮细胞恢复情况。
J Am Coll Cardiol. 2008 Jul 29;52(5):333-42. doi: 10.1016/j.jacc.2008.04.030.